Researchers Rebuild Microscopic Circadian Clock that Can Control Genes
Scientists at UC San Diego and collaborators have reconstituted the minimal cyanobacterial circadian clock using just six proteins, demonstrating precise control of gene transcription through RpaA phosphorylation. The team built a synthetic clock that rhythmically drives a reporter gene in purified components and showed it functions in Escherichia coli. Cryo‑electron microscopy revealed the structural basis of this prokaryotic timing mechanism, distinct from eukaryotic clocks. The work opens pathways for timed bioproduction and deeper insight into biological rhythms.
Merck Foundation Grant Advances Cardiovascular Care for Formerly Incarcerated Black Men
The Merck Foundation has awarded a five‑year, $1.75 million grant to a partnership between University of Chicago Medicine and Lawndale Christian Health Center to improve cardiovascular outcomes for formerly incarcerated Black men in Chicago’s North Lawndale. The program combines clinical management...
UCalgary Research Explores Common Vitamin as Potential Treatment for Aggressive Glioblastoma Brain Cancer
University of Calgary researchers launched a Phase I/II trial testing high‑dose vitamin B3 (niacin) alongside standard surgery, radiation, and chemotherapy for newly diagnosed glioblastoma. The study enrolled 24 patients and reported an 82% progression‑free rate at six months, a 28% improvement...
NIST Awards Over $3M to Small Businesses Advancing AI, Biotech, Semiconductors, Quantum and More
The National Institute of Standards and Technology (NIST) has awarded $3.19 million in Phase II SBIR grants to eight small businesses across seven states. The funding supports research in artificial intelligence, biotechnology, semiconductor, quantum and other advanced technologies, with each award ranging...
A New Inhalable Treatment for Tuberculosis: Once-Weekly Nanoparticles Match Daily Oral Rifampin in Mice
Researchers at the University at Buffalo have created an inhalable nanoparticle that encapsulates rifampin and can be administered once weekly, matching the efficacy of daily oral dosing in mouse models of tuberculosis. The biodegradable particles target lung macrophages, sustain drug...
Versatile Enzyme that Quickly, Accurately Synthesizes RNA Can Also Perform Reverse Transcription
Scientists at UC Irvine have engineered a novel polymerase, C28, that synthesizes RNA at speeds comparable to natural enzymes while maintaining high fidelity. Using directed evolution, the team introduced dozens of mutations that also grant the enzyme reverse‑transcription capability and...
Hypersensitive Detection of Millimeter Vascular Emboli In Vivo
Scientists reported a hypersensitive method to detect single millimeter‑sized vascular emboli in vivo. The technique combines near‑infrared fluorescence imaging with specially engineered adhesive tracers that attach to clot surfaces under physiological blood flow. It enables real‑time, non‑invasive visualization of emboli...
Optimizing Post-Denosumab Treatment Approaches in Non-Metastatic Breast Cancer Patients Undergoing AI Therapy
Aromatase inhibitors (AIs) are cornerstone adjuvant therapies for hormone‑receptor‑positive breast cancer but accelerate bone loss, prompting routine use of denosumab to prevent fractures. While denosumab effectively suppresses bone turnover during AI treatment, abrupt discontinuation triggers a rebound surge in osteoclast...
AI-Generated Arguments Prove Persuasive Despite Disclosure
A new study of 1,601 Americans finds that labeling a message as AI‑generated does not reduce its persuasive power compared with human‑authored or unlabeled content. Across four policy topics, AI‑crafted arguments shifted opinions by roughly 9.7 percentage points, and 92 %...
Unveiling Muscle Viscoelasticity’s Impact in Heart Failure
The VISMARC‑HF study will examine how skeletal‑muscle viscoelasticity correlates with prognosis in older heart‑failure patients. Researchers will recruit participants across disease stages and use advanced imaging and biomechanical testing to quantify muscle elasticity and viscosity. By linking these biomechanical metrics...
Revolutionary AI Model Enhances Precision in Detecting Food Contamination
A new artificial‑intelligence model has been unveiled that dramatically improves the detection of microbial and chemical contaminants in food products. Leveraging multimodal imaging, hyperspectral data, and deep‑learning algorithms, the system reports a 98% detection accuracy across a range of common...
Insilico Medicine and CMS Forge Multiple Collaborations to Accelerate AI-Driven R&D in CNS and Autoimmune Disorders
Insilico Medicine and China Medical System Holdings (CMS) announced a multi‑project partnership to apply Insilico’s Pharma.AI platform to drug discovery for central nervous system and autoimmune diseases. The AI system promises to deliver preclinical candidates within 12‑18 months, a dramatic...
Novel Nanosheets Boost Clot Clearing While Limiting Systemic Bleeding
Researchers in China have unveiled a silicon‑based nanothrombolytic platform that couples urokinase with hydrogenated silicene (SiH) nanosheets and fibrinogen to clear arterial clots. The SiH sheets temporarily inhibit urokinase during circulation, then self‑degrade at the thrombus, reactivating the drug and...
Video: Can Robots Help Save Farming?
Robotics, AI, and automation are reshaping UK agriculture as the Lincoln Institute for Agri‑Food Technology (LIAT) showcases its latest innovations. The institute’s autonomous ARWAC field machine, the data‑rich HiRes‑Soils project, and Saga Robotics’ Thorvald harvest‑assist robot illustrate how technology can...
FDA Kicks Off Review of Takeda's Narcolepsy Hopeful
The U.S. Food and Drug Administration has placed Takeda's orexin‑2 receptor agonist oveporexton (TAK‑861) into a priority review, with a decision expected in the third quarter. If approved, it would become the first drug to target the underlying orexin deficiency...
Evommune Soars as Dermatitis Treatment Rivals Dupixent in Mid-Stage Trial
Evommune’s shares surged 75% after its Phase 2a trial showed the therapeutic protein EVO301 reduced atopic dermatitis severity by 33% versus placebo. The study enrolled 70 patients, with a 55% reduction in the treatment arm compared to 22% in the placebo...
Scientists Identify Genetic Connection to Barrett’s Esophagus, Paving the Way for Advances in Esophageal Cancer Treatment
Researchers at Case Western Reserve University identified mutations in the VSIG10L gene as a key hereditary driver of Barrett’s esophagus, a precursor to esophageal adenocarcinoma. The study analyzed genetic data from 684 individuals across 302 families and demonstrated that loss‑of‑function...
Silent Witnesses: Pets Offer a Fur-Ensic Tale
Researchers at Flinders University and Victoria Police have demonstrated that dogs and cats can act as intermediaries for human DNA transfer at crime scenes. Controlled experiments showed even brief contact leaves detectable DNA on pets, which can then be deposited...
Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. – Announce the Successful Delivery of a Seasonal Influenza Vaccine in...
Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) announced they have completed formulation, aseptic fill‑finish, and clinical packaging for Aramis’s seasonal influenza vaccine. The milestone delivers clinical‑grade material for Phase 1/2 trials, meeting regulatory quality and safety requirements. The achievement underscores...
Biomolecular Condensates in Pro-Β-Carboxysome Assembly
A new Nature Plants study reveals that biomolecular condensates, formed through liquid‑liquid phase separation, drive the multistage assembly of pro‑β‑carboxysomes in cyanobacteria. Scaffold proteins and post‑translational modifications orchestrate condensate nucleation, growth, and a liquid‑to‑gel transition that stabilizes the microcompartment. Environmental...
RegASK Launches AI-Assisted Label Review Delivering Compliance Reports in Seconds Across Global Markets
RegASK unveiled an AI‑Assisted Label Compliance Review that checks packaging labels in seconds across major markets such as the US, EU, UK and China. The tool pairs instant AI analysis with an interactive viewer that highlights violations and links directly...
Astellas’ “Strategic Brands” And “Primary Focuses” After XTANDI
Astellas is reshaping its portfolio as XTANDI nears patent expiry, shifting from a single‑product reliance to a set of “strategic brands.” The company is promoting approved assets such as PADCEV, VYLOY, VEOZAH and IZERVAY to smooth revenue across oncology, menopause...
Women in STEM: Unique Impacts in Rare Disease Development
Klaudia Lechowska, a business‑development specialist at Mabion Biologics, highlighted how STEM education equips women with both technical and commercial skills essential for biotech careers. She noted that women comprise about 60% of the pharma workforce but hold only a quarter...
Perinatal Microplastic Exposure Alters Neonatal Immunity, Metabolism
A new scoping review in the Journal of Perinatology reveals that micro‑ and nano‑plastics can cross the placental barrier and be transmitted through breast milk, exposing fetuses and neonates to particulate pollutants. The exposure triggers chronic inflammation, oxidative stress, and...
AstraZeneca CEO Hails NHS Drug Price Deal but Keeps Pause on £200m UK Investment
AstraZeneca CEO Pascal Soriot praised the UK‑US NHS drug‑pricing agreement as a "very positive step," but said it will not unlock the paused £200 million Cambridge research hub investment. The deal is projected to cost the NHS about £1 billion over its...
New Study Uncovers How Chills Develop and Bolster the Body’s Defense Against Infection
Researchers at Nagoya University identified the brain circuit that generates chills during infection. They showed that prostaglandin E₂ acting on EP3 receptors in the lateral parabrachial nucleus (LPB) triggers warmth‑seeking behavior without invoking shivering. EP3‑positive LPB neurons project to the central...
CSL’s Paul McKenzie Out, as Gordon Naylor Named Interim CEO
CSL Limited announced that CEO Paul McKenzie will step down immediately after more than five years with the Australian biotech group. The board appointed Gordon Naylor, a veteran pharma executive, as interim chief executive. The decision reflects the board’s view...
AstraZeneca’s Obesity Pill Hits in Phase 2, Key Cancer Trials Pushed Back
AstraZeneca announced that its oral GLP‑1 candidate elecoglipron achieved its primary efficacy endpoints in two Phase 2 obesity studies. The trials demonstrated statistically significant weight loss and a favorable safety profile, positioning the drug as a potential first‑in‑class oral therapy. Simultaneously,...
Retraction: Circular RNA 0000096 and Gastric Cancer Insights
British Journal of Cancer retracted a 2026 study that claimed circular RNA 0000096 promotes gastric cancer cell proliferation and migration. Independent labs were unable to replicate the results, uncovering weaknesses in experimental design, statistical analysis, and control use. The authors withdrew...
'Bat-Sh*t Crazy': Biopharma Leaders Unload on Regulatory Chaos
The provided excerpt contains only the title and a brief introductory sentence of an article about biopharma executives criticizing regulatory complexity, without the full body text. Consequently, no substantive details about specific comments, companies, regulatory issues, or market impacts are...
STAT+: Eczema Drug From Nektar Therapeutics Maintains Skin Responses in One-Year Study
Nektar Therapeutics reported that its experimental eczema biologic rezpeg sustained stringent skin‑lesion improvements in a year‑long maintenance study. Patients receiving monthly injections maintained responses in 71% of cases, while quarterly dosing achieved an 83% maintenance rate. The data met or...
AI Stethoscope Identifies Early Signs of Heart Valve Disease, Outpacing Traditional GP Diagnoses, Study Reveals
A new AI‑powered stethoscope can spot early signs of heart valve disease up to 30% sooner than conventional general‑practice examinations, according to a multi‑center study. The research evaluated 1,200 patients across three hospitals, comparing the algorithm’s acoustic analysis to physician...
Mapping Agrobiodiversity for Nutrition in South Asia
A new spatial analysis published in npj Sustainable Agriculture maps crop species and functional diversity across South Asia, revealing that high species richness does not automatically translate into functional diversity. The researchers integrated geospatial datasets with ecological metrics to identify...
Exploring Belgium’s Livestock Transition: Narratives and Trade-Offs
Researchers in npj Sustainable Agriculture present a comprehensive study mapping Belgium’s livestock transition using narrative‑driven scenario analysis. The work identifies key trade‑offs between emission reductions, farm profitability, and social acceptance, while evaluating technologies from precision manure handling to cultured meat....
Lupin Settles Myrbetriq Patent Spat with Astellas for $90m
Lupin has agreed to pay $90 million to settle U.S. patent litigation with Astellas over the over‑active bladder drug Myrbetriq. The settlement includes a $75 million option payment and ongoing per‑unit license fees until Astellas' patent expires in September 2027. The deal lets...
Sava Reports World-First 10-Day Clinical Evidence for Continuous Glucose Monitoring
Sava Technologies announced the first 10‑day clinical evidence for continuous glucose monitoring using its proprietary microsensor technology. In an independent study of 46 Type 1 and insulin‑dependent Type 2 diabetes patients, the microsensor showed a mean absolute relative difference (MARD) within 0.8...
Tracking Post-Acute Infection Syndromes Over Time
Researchers introduced latent transition analysis (LTA) to map the longitudinal trajectories of post‑acute infection syndromes (PAIS), revealing distinct symptom phenotypes and their transition probabilities. By integrating symptom scores, biomarkers, and patient‑reported outcomes across multiple time points, the study quantified how...
UK’s Brightest Young Scientists Named Finalists for Largest Unrestricted Science Prize
The Blavatnik Family Foundation and The New York Academy of Sciences announced the nine finalists for the 2026 UK Blavatnik Awards for Young Scientists, covering Life Sciences, Chemical Sciences, and Physical Sciences & Engineering. Three laureates will receive £100,000 each, while the remaining...
Evinova and Bristol Myers Squibb Launch AI Collaboration for Clinical Trials
Evinova announced a strategic agreement with Bristol Myers Squibb to deploy its AI‑native Cost Optimizer module across BMS’s global clinical trial portfolio. The platform leverages agentic AI, USDM data standards, and a Unified Trial Solution that blends eCOA, telehealth, and...
Key Molecular Factor Behind Nav1.7 Inactivation Uncovered
A collaborative research team has identified a previously unknown molecular factor, termed Factor X, that governs the rapid inactivation of the Nav1.7 sodium channel. Using cryo‑electron microscopy and electrophysiological assays, the study shows that Factor X binds to a specific intracellular loop,...
HER2’s Digital Rebirth Is Unlocking the Full Potential of ADCs
The latest wave of antibody‑drug conjugates (ADCs) hinges on precise HER2 quantification, and digital pathology combined with AI is delivering that accuracy. By analyzing gigapixel slides, AI models can detect low and ultra‑low HER2 expression that traditional microscopy often misses,...
Abio Technologies Launches Abio Spark and Blaze at SLAS2026
Abio Technologies unveiled its AI‑first software suite at SLAS2026, introducing Abio Spark and Abio Blaze. Spark is a free, integrated electronic lab notebook and inventory system aimed at academics and startups. Blaze is an AI‑powered orchestration platform that connects heterogeneous...
Unchained Labs Explodes Into AI-Driven Automation, Launches Stuntman
Unchained Labs unveiled Stuntman, an AI‑driven automation platform that lets scientists command experiments using natural‑language prompts. The system embeds a large‑language model to translate plain‑text instructions into executable workflows while offering deep programmatic control when needed. Its modular hardware architecture...
AI Reads Brain MRIs in Seconds and Flags Emergencies
University of Michigan researchers unveiled Prima, a vision‑language AI that reads brain MRIs in seconds and flags urgent cases. In a study of over 30,000 scans, Prima achieved 97.5% accuracy across more than 50 neurological diagnoses and could prioritize emergencies...
Parents of Medically Complex Children Face Significant Challenges with At-Home Medical Devices
A recent study by the Stanley Manne Children’s Research Institute, published in Pediatrics, reveals that parents of medically complex children face serious safety and usability issues with at‑home medical devices. Interviews with 17 caregivers highlighted device malfunctions, confusing interfaces, and...
Facing Talent Crunch, Radiopharma Field Casts a Wide Net
Investment in radiopharmaceuticals is driving a fierce talent shortage as big‑pharma players like AstraZeneca, Novartis and Eli Lilly expand into the modality. The success of lutetium‑177 therapies such as Lutathera and Pluvicto has sparked a surge in clinical studies, intensifying demand...
Symptoms Impacting Health Quality in Swedish Older Men
Researchers published a cross‑sectional study in BMC Geriatrics examining symptom prevalence among Swedish men aged 65 and older and its impact on health‑related quality of life. The survey identified joint pain, fatigue, anxiety and depression as the most common complaints,...
Elevated Mortality Rates in Youth and Young Adults with Autism Spectrum Disorder, Intellectual Disability, or Cerebral Palsy
A JAMA Pediatrics study finds youth and young adults with autism, intellectual disability, or cerebral palsy face markedly higher mortality than peers. Standard death‑certificate coding severely under‑captures these deaths, creating hidden disparities. By linking alternative health data, researchers documented excess...
Modulated UV-C Light Increases the Shelf Life of Guavas, Study Shows
Researchers at Brazil's EMBRAPA have demonstrated that modulated UV‑C light—delivered in pulses rather than continuously—effectively suppresses anthracnose fungus on guavas, extending their post‑harvest shelf life. The treatment uses a cylindrical chamber with three strategically positioned UV‑C lamps that maximize surface...
Start-Up Funding, the Perils of Compounding, and Neuropsych Insights — a BioCentury Podcast
BioCentury reports that 2025 ended a four‑year decline in biotech series A financing, with 144 companies raising $8 billion. The “BioCentury This Week” podcast highlights which venture‑capital‑backed firms attracted capital and what the trends indicate for emerging technologies. Washington editor Steve Usdin...
